DERMATOLOGÍA PERUANA - VOL. 10, Nº 1, ENERO - JUNIO 2000


REFERENCIAS BIBLIOGRÁFICAS


1. Spector RJ. Kawasaki disease. En Demis DJ editor Clinical Dermatology Vol. II Philadelphia. Lippincott Raven Publisher, 1996

2. Vicaíno-Alarcon A. Arévalo-Salas A, Rodríguez López AM, Sadowinski Pine S Enfermedad de Kawasaki en niños mexicanos Bol Med Hosp Infant Mex 1991; 48 398-408

3. Taylor JFN Kawasaki is disease. Br Med J 1987, 294:1.112-1.113

4. Friter BS, Lucky AW. The perineal eruption of Kawasaki syndrome. Arch Dermatol 1978, 124, 1805-10.

5. Kahn G Mucoctaneous lymph node syndrome (Kawasaki´s disease). Arch Dermatol 1978, 114: 948-50.

6. Frieden U, Resnick SID Exantemas de la niñez Antiguos y nuevos. Clin Pediatr NA 1991;1 4:911-912.

7. Kfyzer TC, Derkay CS Kawasaki disease: five year experience at Children´s National Medical Center. Int j Pediatr Otorhinolaryngol 1992, 23:211-20

8. St John MA, Ishmale RG Outocome of Kawasaki disease in Barbados. West Indian J 1992; 41: 68-71

9. Treadwell PA Recent advances in pediatric dermatology En: Callen J. Dahl M, Golitz L, Rasmussen, Stegman S, editores. Advances in dermatology Chicago Yearbook Medical Publisher Inc 1987, p, 108-125.

10. Bell DM, Brink EW, Nitzkin JL, et al. Kawasaki syndrome description of two outbreaks in the United States N Engl J Med 1981, 304: 1568-75

11. Fisher M, Trusky DE Fever and rush update. Fn. Moschella SL, editor. Dermatology Update 2ª Ed New York Elsevier, 1982, p 71-74

12. Hurtwitz S. Clinical pediatric dermatology 2ª ed. Philadelphia: WB. Saunders Company, 1993, p, 543-549.

13. Bell DM, Morowe DM, Holman RC, et al. Kiwasaki syndrome in the United States Am-Dis Child 1983, 137: 211-4.

14. Sclossberg D, Kandra J, Kreiser J Possible Kawasaki disease in a 20 years old woman. Arch Dermatol 1979, 115: 1435-6.

15. Gersony WM. Diagnosis and management of Kawasaki disease JAMA 1991, 265: 2699-703.

16. González-Galnares M Urbán-Vásquez H, Santa Mana-Díaz H, Gorbea Robles C Enfermedad de Kawasaki en México: análisis de 13 casos. Bol Hosp Infant Mex 1991, 48: 409-16.

17. Herrera-Labarca P Oroz-Montigio J, Vargas-Marietar S Enfermedad de Kawasaki (síndrome mucolinfocutáneo). Pediatria 1982, 25: 108-12.

18. Marquez J, Faingezicht I. Síndrome mucocutineo linfonodular (enfermedad de Kawasaki) en el Hospital Nacional de Niños, Rev Med Hosp Nac Niños 1986, 21: 159-78.

19. Muñoz S, Perez S, Zubillaga A, Sanabria T. Síndrome nodulolinfocutáneo de Kawasaki. Arch Venez Pueric Pediatr 1984 , 47: 20-30.

20. Mendoza J, Perez C, Mena R Enfermedad de Kawasaki. Reporte de los primeros 5 casos en la Republica Dominicana. Arch Domin Pediatr 1986, 22 127-131

21. Alvarado JC, Hurtado L. Síndrome linfocutáneo infantil, enfemedad de Kawasaki. Salud Boliv 1983: 1: 109-12.

22. Moreno M, Ramos L. Martínez E, Consuegra R. Enfermedad de Kawasaki (síndrome ganglionar mucocutáneo), presentación de un caso. Rev Cuba Pediatr 1989; 61: 579-85.

23. Larralde de Luna M, Cuttica J Vásquez H, Magnin P Enfermedad de Kawasaki. Comunicación de un caso. Arch Argent Pediatr 1984, 82: 268-74.

24. Sariva LR, Brinduro-Fillho D, Barros GS, et al. Kawasaki disease in Pernambuco, Brazil. Considerations on a case seen in a general Hospital. Arq Bras Cardiol 1992, 58: 43-6.

25. Windsor AM, Schell WL, Davis JP Kawasaki syndrome in Wisconsin. Wis Med J 1991, 90: 227-31

26. Yanagawa H Yashiro M, Nasamura y et al Epidemiologic pictures of kawasaki disease. Acta Peciatr 19941 83 1057-60

27. Bulow SL, Hansen D, et al. Kawasaki synclom forekemost i Danmark i perioden 1981 1981-1990. Egeskr Laeger 1994, 156 48 13-48 16.

28. Taulbert KA, Rowley AH, Shulman ST Seven year national survey of Kawasaki disease and acute rheumatic fever Pediatr Infect Dis 1994, 13 704-8.

29. Fuhushige J, Tahashi N, Ueda Y Ueda K. Incidence and clinical features of incomplete Kawasaki disease Acta Peckatr 1994, 83; 1057-60.

30. Everet D. Acute febrile mucocutaneous lymph node syndrome Kawasaki syndrome. Int J Dermatol 1982, 21 506-9.

31. Abe J, Kotzin BL, Jujo K, et al Selective expansion of T cells expressing T cell receptor variable regions V beta2 and V beta8 in Kawasaki disease? Proc Nati Acad So USA 1992: 89 4066-70.

32. Furukawa S, Imai K, Matsubari T et al Increased level of circulating intercellular adhesion molecule I in Kawasaki disease. Arthritis Rheum 1992, 36: 672-7

33. Kenko K, Savage CO, Pottiger BE, et al Antiendotelial cell antibodies can be cytotoxic to endotelial cells without cytokine pre-stimulation and Correlate with ELISA antibody measurements in Kawasaki disease Clin Exp Immunol 1994 , 98: 264-9

34. Lin CY Lin CC, Hwang B, Chiang BN. The changes of interleukin 2, tumor necrotic factor and gamma interferon production among patients with Kawasaki disease, Fur J Pediatr 1991, 150 179-82.

35. Kim DS, Lee KY Serum soluble E selectin levels in Kawasaki disease Scand J Rheumatol 1994; 23: 283-6.

36. Kobayashi S, Wada N, Kobe M Antibodies to native type III collagen in the serum of patients with Kawasaki disease. Eur J Pedratr 1992; 151: 183-187

37. Soppi E, Salo E, Pelkonen P Antibodies against neutrophil cytoplasmic components in Kawasaki disease APMIS 1992, 100 269-72.

38. Motohashi T Serum soluble CD4 y CID levels in Kawasaki disease Arerugi 1992, 41: 140-7

39. Iwata F. Hanawa Y Takshima H, et al Kawasaki disease in father and son Acta Pediatr Jpn 1992, 34 84-6.

40. Del Castillo MF. Enfermedad de Kawasaki Una enfermedad olvidada en nuestro país? Piel 1996, 11: 333-5

41. Rauch AM, Glode MR Wiggins JW Jr, et al. Outbreak of Kawasaki syndrome in Denver, Colorado associations with rug and carpet cleaning Pediatrics 1991;87:663-9.

42. Kanegane H, Tsuji T, Seki H, et al. Adult Kawasaki syndrome associated with HIV infections and anticardiolipins anti bodies. J Am Acad Dermatol 1993, 29: 663-4.

43. Schulz TF. Hoad JG, Whetby D, et al. A measles virus isolated front a child with Kawasaki disease sequence comparison with contemporaneous isolates from classical cases. H Gen Virol 1992, 73: 81-6.

44. Rowley AH, Wolinsky SM, Relman DA, et al. Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease Pediatr Res 1994, 36: 567-71.

45. Person-R. Kawasaki disease and staphylococcal exotoxins Arch Dermatol 1980, 116:986.

46. Waanders H, Thommon J Kawasaki syndrome after treatmet it with mesalazine. Am J Gastroenterol 1991, 86: 219-21

47. Curtis N, Zbeng R, Lamb JR, Levin M Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child 1995, 72: 308-11.

48. Maytepeck F, Lehman WD Increased generation of cysteril eulkotrienes in Kawasaki disease. Arch Dis Child 1995, 72 526-7

49. Bader-Meunier B, Hadchanel M, Fabre M et al. Intrahelpatic bile duct damage in children with Kawasaki disease J Pediatr 1992, 120 750-2.

50. Sacco MC, Meieleo D, Castriota Scanderberg A Hydrocele in Kawasaki disease. Pediatr Med Chir 1995, 17: 279-80

51. Mauriello JA, Stabile C, Wagner RS Dacryocystitis following Kawasaki's disease. Ophtal Plast Reconstr Surg 1986, 2: 209-11

52. Kazi A, Gauthier M, Lebel MH, et al. Ovulitis and supraglotitis: early manifestations of Kawasaki disease. J Pediatr 1992; 120: 564-7.

53. Furukawa F Lipodystrophy centrifugalis ilbdominalis infintilis A possible sequel to kawasaki disease. Int J Dermatol 1989, 28: 338-9.

54. Hullyer CD, Schwen MR, Fulton DR, et al Autoinmune hemolytic anemia in Kawasaki disease: a case report Transfusion 1990, 30 738 10.

55. Fujiwara S, Yamano T, Hattori M, et al. Asymptomatic cerebral infractions in Kawasaki disease Pediatr Neural 1992; 14: 12 1-6,

56. Miyake T, Tokoyan a T, Shinohara T, et al. Transient dilatation of the albdominal aorta in air infant with Kawasaki disease associated with tombocytopenia. Acta Pediatr Jpn 1995, 37: 52 1-5.

57. Biyrou O, Philippteau C, Atirtigan C, et al Aduit Kawasaki syndrome associated with HIV infection and anticardiolipins antibodies. J Am Acad Dermatol 1993, 29: 663-4.

58. Velga PA, Pieroni D, Baier W, Fed LG Association of Kawasaki disease and interstitial nephritis Nelphrol 1992, 6: 421-3

59. Ciofu PA, Laky D, Geormaeaunu M Kawasaki disease in an infantil in an infant with cystic fibrosis Rom J Morphol Embryol 1992, 38: 63-6

60. Butler DF, Hough DR, friedman SJ. et al Adult Kawasaki syndrome. Arch Dermatol 1987, 123: 1356-61

61. Akita H Matsuoka S, Takanashi Y et al Kawasaki disease-like disease in early course of acute monocytic leukemia. Eur J Pediatr 1992; 151: 177-8

62. Korem G, Silverman E, Sundel R, et al. Decreased protein binding of salicylates in Kawasaki disease.. J Pediatr 1991; 18: 456-9.

63. Comenzo RL, Malachovski ME, Meissner HC et al. Inmune hemolysis, disseminated intravascular coagulation and serum sckiness after large doses of immune glolbulin given intravenously for kawasaki disease. J Pediatr 1992; 120: 296-8.

64. Furukawa S. Matsubara T, Jujoh K et al. Reduction of peripheral blood macrophage/monocytes in kawasaki disease by intravenous gammaglobulin. Eur J Pediatr 1990; 150: 43-7.

65. Mori M, Tomono N, Yokota S Coronary arteritis of Kawasaki disease unresponsive to high dose intravenous gammaglobulin successfully treated with plasmapheresis. Nihon Rinsho Meneki Gakkai kaishi 1995; 18: 282-8.

66. Furukawa S, Matsubara T, Umezawa Y, et al. Pentoxifylline and iritravenous gammaglobulin combination therapy for acute kawasaki disease Eur J Pediatr 1994, 153. 663-7

67. Chapel KL, Rasmussen JE Pedicitric Dermatology advances in therapy J Am Acad Dermatol 1997, 36: 513-26.

68. Gudiel A, Castro I, Kikushima I, et al. Enfermedad de kawasaki y respuesta al tratamiento con un ácido aceltisalicílico y gamaglobulina humana endovenosa: reporte de un caso. For Dermatol Peruana 1994; 5: 41-43.

69. Hicks. RV, Melish ME Síndrome de Kawasaki. Clinica Pediatr NA (ed. esp.) 1986; 5: 205-29.

70. Baldwin HS. Que hay de nuevo en cardiología. Pediatr Rev Esp 1996; 16: 33-7.

71. Chechia PA, Pahl E, Shaddy SE, Shulman St. Cardiac trarnplantation for Kawasaki disease Pediatrics 1997, 100 695-70 1,

72. Guerrero-Vásquez J Collantes-García C. La Enfermedad de Kawasaki También un laberinto conceptual y terminológico. Acta Ped Fsp 1996, 54 389.

73. Melish ME Kawasaki Syndrome Red Rev. 1996; 17 153-62: se consigue en: URL. http://www.mdconsult.com

74. Kuniyuki S, Asada M. An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease J Am Acad Dermatol 1997; 37: 303-4.

75. Tincopa Wong O. Albuquerque-Fernández P Mora-Flores E, Aranguri-Vera R. Enfermedad de Kawasaki. Primeras observaciones en el norte peruano. Piel 1998, 13: 446-53.

76. Saettone A, Cáceres-Ríos H. Enfermedad de Kawasaki Dermatol Per 1997; 7: 59-64.

77. Taubert K, Shulman S. Kawasaki disease Am Fam Phys June 1999. En URL: http://www.aafp/org/afp/990600ap/3093.htm/html

78. Guerrero-Femández J. Enfermedad de Kawasaki web. Pediátrica Agosto 1999 En URL: www.medynet.com/usuarios/webped/aa.htm

79. Resúmenes del VI Congreso Peruano de Dermatología, 710 Noviembre de 1996, Lima, Perú. Dermatol Perú (Edición especial) Noviembre 1996.

80. Leung DY Meissner HC, Fulton DR, et al. Toxic shock syndrome toxin secreting Staphylococcus aureus isolated from patients with kawasaki syndrome. Infect Inmmun 1996; 64: 3394-6.

81. Terai M, Miwa K, Williams T. Et al. The Absence of evidence of staphylococcal toxin involvement in the pathogenesis of kawasaki disease. J Infect 1995; 172: 558-61.

82. Gallagher PG. Facial nerve paralysis and Kawasaki disease Rev Infect Disease 1990; 12: 403-5

83. Terasawa R, et al Neurological complications in Kawasaki disease Brain Develop 1983; 5: 371-4

84. Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age J Pediatr 1995; 126: 524-9

85. Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of kawasaki disease in children Circulation 1993; 87: 1776-80.

 

REGRESAR AL ARTÍCULO

 


Regresar